PARATEK PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1996-01-01
- Employees
- 268
- Market Cap
- -
- Website
- http://www.paratekpharma.com
Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
Phase 3
Withdrawn
- Conditions
- Skin Structures and Soft Tissue Infections
- Interventions
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2012-05-09
- Lead Sponsor
- Paratek Pharmaceuticals Inc
- Registration Number
- NCT00876850
Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
Phase 3
Terminated
- Conditions
- Skin Diseases, Infectious
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- Paratek Pharmaceuticals Inc
- Target Recruit Count
- 143
- Registration Number
- NCT00865280
- Locations
- 🇺🇸
Paratek Recruiting Site, Savannah, Georgia, United States
🇺🇸Parateck Recruiting Site, Columbus, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath